SecBot SecBot

IVVD

Invivyd, Inc.
Nasdaq· Biological Products, (No Diagnostic Substances)· Inc. DE· CIK 0001832038 Biotech & Drug Discovery
$0.5380 −0.04 (−7.56%)
Nov 16 4:00 PM ET · prev $0.5820
Market cap
$171.6M
Micro cap
Consensus
Buy
89% Buy or better · 9 analysts
Median target
🔒 Subscribers only
1 year
−81.1%
from $2.84 · Nov 17
30 days
−11.8%
from $0.6100
52-week range
$0.5350–2.88
−81% from high · low Jul 31
Avg volume 20D
3.79M
shares / day
Short interest
36.20M
≈12.3% of shares · −2.3%
Days to cover
9.7
at average volume
Insider net
−$177.1K
0 buyers · 5 sellers · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
11
analyzed by SecBot
SecBot read MIXED 5 reports · 90 days
Balance 0 bearish · 1 bullish · 1 mixed · 3 neutral oldest → newest, height = score
Avg score ·High conf. 3/5

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    5 insiders sold $177.1K.

  • InstitutionsBULLISH

    Q3 2026: 18 added (0 new), 9 trimmed or exited.

  • AnalystsBULLISH

    8 of 9 rate it Buy or better.

  • Short sellersSTEADY

    Short interest −2.3% to 36.20M shares. 9.7 days to cover, ≈12.3% of shares.

  • TrendDOWNTREND

    25% below its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Nov 7.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
Qube Research & Technologies LtdTRIM1,879,617$1.6M
UBS Group AGADD797,773$694.1K
JPMORGAN CHASE & CODOUBLED454,733$386.6K
BARCLAYS PLCDOUBLED231,363$201.3K
RHUMBLINE ADVISERSADD198,555$172.7K
Vanguard Global Advisers, LLCADD108,418$94.3K
Quantinno Capital Management LPDOUBLED98,688$85.9K
BNP PARIBAS FINANCIAL MARKETSADD77,419$67.4K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

9 analysts
Buy 89% rate it Buy or better
Strong Buy3Buy5Hold1Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Sep 14, 2026BTIG
REITERATE
REITERATEBuy
Aug 27, 2026Cantor Fitzgerald
REITERATE
REITERATEOverweight
Jul 7, 2026BTIG
REITERATE
REITERATEBuy
Jun 15, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy
Jun 9, 2026BTIG
REITERATE
REITERATEBuy
Jun 1, 2026BTIG
REITERATE
REITERATEBuy

Washington

Corporate Lobbying

13 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$0
bought · 0 insiders
$177.1K
sold · 5 insiders
DateInsiderTypeValue
Aug 31, 2026
Sheffield Ian
Director
Aug 31, 2026
AWARD100,000 sh
Aug 30, 2026
Elia Marc
Chief Executive Officer
Aug 30, 2026
AWARD10,700,000 sh
Aug 18, 2026
Allen Robert D. III
Chief Scientific Officer
Aug 18, 2026
SELL$14.4K
Aug 18, 2026
Duke William E.
Chief Financial Officer
Aug 18, 2026
SELL$15.5K
Aug 18, 2026
Andersen Jill
Chief Legal Officer, Secretary
Aug 18, 2026
SELL$25.9K
Aug 18, 2026
Lee Timothy Edward
Chief Commercial Officer
Aug 18, 2026
SELL$15.5K
Aug 18, 2026
Green Julie
Chief Human Resources Officer
Aug 18, 2026
SELL$15.5K
Aug 17, 2026
Allen Robert D. III
Chief Scientific Officer
Aug 17, 2026
SELL$14.9K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Reddit Mentions per day, 14 days
Recent posts
All social signals and their track records

Short side

FINRA· Oct 30, 2026
36,204,545
shares short
-2.3%
vs prior settlement
9.7
days to cover
≈12.3%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 16, 2026 Earnings
🔒 Fresh data, subscribers only
Nov 3, 2026 Press
Invivyd granted 175,000 stock options to seven new non-executive employees as a material inducement for employment…
Impact 2/10
Sep 30, 2026 Inst.
Qube Research & Technologies · TRIM
1,879,617 shares ($1.6M)
Sep 30, 2026 Inst.
UBS Group AG · ADD
797,773 shares ($694.1K)
Sep 29, 2026 SEC
Invivyd announced positive topline results from the LIBERTY Phase 3 study, showing VYD2311 met all primary and…
8-K · Impact 7/10
Sep 22, 2026 SEC
Institutional activity in IVVD during 2026-Q2 was mixed: 19 buyers added $1.9M in new holdings (led by Citadel, Morgan…
INST-CLUSTER · Impact 3/10
Aug 31, 2026 Insider
Sheffield Ian was granted 100,000 shares
Director
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
1 drug tracked · Drug pipeline →
Recent

SecBot reports

11 filings · 8 press releases · 2 bullish · 1 bearish · 3 mixed · 5 neutral
All IVVD filing & press-release reports (19)